The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular research 2021-07, Vol.117 (9), p.e110-e113
Hauptverfasser:	Pessoa-Amorim, Guilherme, Mafham, Marion M
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Cardiovascular Diseases - diagnosis Cardiovascular Diseases - drug therapy Cardiovascular Diseases - mortality Cardiovascular Research Onlife Cause of Death COVID-19 - diagnosis COVID-19 - mortality COVID-19 Drug Treatment Female Fibrinolytic Agents - adverse effects Fibrinolytic Agents - therapeutic use Heart Disease Risk Factors Humans Male Middle Aged Research Design Risk Assessment Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!